Thursday’s Insider Trades: Top Buys and Sells in US Stocks Revealed

Published 05/09/2025, 14:02
Thursday’s Insider Trades: Top Buys and Sells in US Stocks Revealed

This article summarizes the most significant insider buys and sells from Thursday, September 4, 2025, for US stocks.

Top Insider Buys:

American Strategic Investment Co. (NASDAQ:NYC) saw notable insider purchases over two days. Entities associated with Nicholas S. Schorsch acquired a total of 664 shares of Class A common stock at prices ranging from $10.02 to $10.96, for a combined value of $7,029. These purchases come as the micro-cap company, valued at $28.82 million, faces challenges with its stock declining nearly 9% over the past week. Despite these difficulties, InvestingPro analysis suggests the stock may be undervalued.

Top Insider Sells:

Ionis Pharmaceuticals Inc (NASDAQ:IONS) reported significant insider selling activity. Patrick R. O’Neil, Executive Vice President, CLO & General Counsel, sold 90,400 shares of common stock over two days, fetching prices between $54.5148 and $61.42, for total proceeds of approximately $5.39 million. These sales were related to the exercise of stock options, where O’Neil acquired 89,900 shares at prices ranging from $32.6 to $53.77.

Ionis Pharmaceuticals Inc (NASDAQ:IONS) also saw its Chief Executive Officer, Monia Brett P, sell 206,914 shares of common stock for a total of $12,294,703. The sales occurred at weighted average prices between $59.119 and $61.0629 per share. This activity coincides with the stock trading near its 52-week high of $62.08 and showing remarkable momentum with a 39.2% return in the past week.

Carvana Co. (NASDAQ:CVNA) reported that Chief Executive Officer Ernest C. Garcia III, through trusts, sold 9,813 shares of Class A Common Stock for approximately $3.65 million. The sales were executed at prices ranging from $360.38 to $370.91 under a Rule 10b5-1 trading plan adopted in December 2024.

Microsoft (NASDAQ:MSFT) Chief Executive Officer Satya Nadella sold 149,205 shares of the company’s common stock for approximately $75.3 million. The sales were executed at prices ranging from $503.0039 to $507.558 per share. This activity occurs as Microsoft’s market capitalization stands at $3.77 trillion, with the stock showing strong momentum, gaining over 31% in the past six months.

INSMED Inc (NASDAQ:INSM) Chief Medical Officer Martina Flammer sold shares of common stock at prices ranging from $141.27 to $146.05, totaling $26.9 million. This transaction followed the exercise of stock options to acquire 175,646 shares at prices between $17.07 and $34.03.

Investors should stay tuned to insider trading activity as it can provide valuable insights into a company’s prospects. While insider buying may signal confidence in the company’s future, selling can occur for various reasons and doesn’t necessarily indicate a negative outlook. It’s essential to consider these transactions alongside other financial metrics and market conditions when making investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.